LEADING THE WAY IN CELL THERAPY

About MedXCell Science

MedXCell Science is a French Life science company active in the field of regenerative medicine. With the CHU of Montpellier as a shareholder and leveraging on its expertise, it is currently completing a clinical trial phase 2 (ADIPOA-2) for its allogeneic cell therapy treating mild to moderate knee osteoarthritis.

MedXCell Science results from the meeting between the University professor Christian Jorgensen (CHU Montpellier) and the entrepreneur Laurent Zbinden. The two founded MedXCell Science in 2018 together with the CHU of Montpellier, Prof. Noël and Prof. De Vos.

“Our ambition is to become the leader in providing cell-therapy products for sports medicine and the fight against ageing.”

Christian Jorgensen & Laurent Zbinden

Founders

Our Vision

Help people enjoy a better, longer and healthier life

Our Mission

Develop and deliver innovative cell therapy treatments that improve people’s quality of life and mobility

Our Values

Innovation

We continuously strive to find disruptive and innovative solutions

Ethical

Human respect and ethics - no dedicated tissue harvesting

Patient Centered

We develop affordable therapies that make a real and positive difference to the greatest number of patients

Passion

We are committed in heart and mind to what we do